Diffuse panbronchiolitis (DPB) is a clinicopathological entity which was identified at the end of the 1960s. It is fairly common in Japan where 82 histologically proven cases had been reported by 1983 . ' However, DPB In June 1994, during an acute exacerbation, a new CT scan showed an increase in diffuse small round opacities distributed mainly around the ends of the bronchovascular branches and in the centrilobular regions (fig 1) . Subsequent histopathological re-ex- amination of the open lung biopsy specimens resulted in a diagnosis of DPB on the basis of diffuse histopathological changes mainly affecting the respiratory and terminal bronchioles and the centrilobular regions (fig 2) . Human leucocyte antigen (HLA) typing was performed but no HLA B54 antigen was found.
From July 1994 onwards a low dose of erythromycin (500 mg daily) was instituted and produced a remarkable improvement. Cough and sputum production disappeared and exertional breathlessness decreased. Chest radiography disclosed a significant reduction in the number of small nodular shadows. Three months later corticosteroids and azathioprine therapy could be stopped, and pulmonary function tests exhibited values which were closer to normal than any recorded during the previous eight years: FEV1 Discussion DPB is a clinicopathological entity with the following clinical diagnostic criteria': (1) chronic cough with sputum and exertional dyspnoea; (2) physical signs of coarse crackles and rhonchi; (3) chest radiograph showing disseminated fine nodular shadows, mainly in the lower lung fields, with hyperinflation of the lungs; and (4) pulmonary function tests showing at least three of the four following abnormalities: (a) FEVI <70%; (b) VC <80% predicted; (c) RV >150% predicted; (d) Pao2 <10.6 kPa. In addition, nearly all patients have chronic paranasal sinusitis, as in the present case. Histologically there is diffuse chronic inflammation located in the centrilobular region, with distinctive interstitial accumulation of foam cells and lymphoid cells in the walls of the respiratory bronchioles, adjacent alveolar ducts, and alveoli for which the term "unit lesion of DPB" has been used.24 Histological confirmation is important because the clinical diagnostic criteria ofDPB have sometimes been observed in patients affected by other lung diseases such as chronic bronchitis, emphysema, bronchiectasis, and bronchiolitis obliterans'4 in which the "unit lesion of DPB" or "DPB-like lesion" is not found. 4 Although HLA analysis of patients with DPB has demonstrated a significant increase in the frequency of HLA Bw 54,6 its absence, as in our patient's case, does not make the diagnosis any less relevant. HLA Bw 54 is only found in Asians and never in Caucasians or black subjects.6 This might explain why the disease is widespread in the Far East and remains rare in Europe and North America.
In Western countries only a few cases of DPB observed in Asian immigrants have been published.234 In view of the large numbers of Asians in North America and Europe, the fact that so few of them are affected by the disease remains intriguing and suggests that it might have other causes besides genetic factors.
In our patient the diagnosis of DPB was delayed, as it was with some of the few cases reported outside the Far East,347 underlining the difficulty in identifying this rare disease in Western countries. This emphasises the value of re-examining the open lung biopsy specimen of all patients suspected of having DPB, because correct treatment with erythromycin is generally effective. Similarly, the CT scan pattern of our patient -with its particular topography of small nodules located in the centrilobular area and connected to the ends of bronchovascular branches -is fairly typical of the disease before its final stage during which non-specific bronchiectasis appears.8 In the differential diagnosis of diffuse pulmonary disease (that is, sarcoidosis), such a CT scan pattern may permit orientation ofthe diagnosis.
Our patient had been taking high doses of prednisone for eight years with an incomplete response, thus confirming previous observations that DPB was only partially responsive to corticosteroid treatment.' 3 4 7 9 Long term treatment with low dose erythromycin is now preferred since the first description of its efficacy a few years ago.5 Its mechanism of action, which appears to be speculative, might prevent neutrophils from migrating towards inflammatory sites of the lung."1 The excellent response to low dose erythromycin was confirmed in our case and enabled us to stop long term corticosteroid treatment and other immunosuppressive therapy which had been administered for eight years before definitive diagnosis.
This report highlights the value of re-examining the open lung biopsy specimen of patients suspected of having DPB. The efficacy of long term erythromycin therapy in DPB makes it important to know how to identify the disease, the frequency of which may be underestimated in Western countries. With this in mind, open lung biopsy specimens should be re-examined in all patients who present with clinical criteria of DPB for whom no definitive diagnosis has been established.
